Poxel Gets $17.1 Million to Advance Type 2 Diabetes Drug Trial
Poxel Gets .1 Million to Advance Type 2 Diabetes Drug Trial
Filed under: drug treatment news 2010
The next trial will test the drug as a stand-alone treatment on 400 patients beginning in early 2013, with data expected a year later, Kuhn said. Type 2 diabetes is the … Poxel raised 16 million euros in July 2010 from the same investors. The company …
Read more on Bloomberg
Michael Douglas' Drug-Addict Son Cameron Attacked in Prison
Filed under: drug treatment news 2010
The presiding judge also banned him from receiving family visits for two years and enlisted him in a prison drug treatment programme. Michael … In 2010 the Basic Instinct star admitted that prison might be a "blessing in disguise" for his son. He …
Read more on IBTimes.co.uk
Pharmalink Initiates a Pivotal Phase IIb Trial with Nefecon® in Patients with …
Filed under: drug treatment news 2010
Pharmalink hopes to bring a new medicine to patients for early treatment, halting disease progression and further loss of renal function. We look forward to confirming … Nefecon® is delivered using the proprietary TARGIT® drug delivery technology …
Read more on The Herald | HeraldOnline.com